会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NEW LOW SIDE EFFECT PHARMACEUTICAL COMPOSITION CONTAINING ISONIAZID
    • 新的含有ISONIAZID的低效药物组合物
    • US20110207684A1
    • 2011-08-25
    • US13059929
    • 2008-07-23
    • Yoapu Oliver HuTon Ho Young
    • Yoapu Oliver HuTon Ho Young
    • A61K31/7048A61K31/4409A61K31/661A61P31/06
    • A61K45/06A61K31/4409A61K31/6615A61K31/7048A61K2300/00
    • The present invention features a novel, low side-effect pharmaceutical compound complex, comprising the pharmaceutically effective dose of isoniazid (INH) and pharmaceutically effective dose of one of the following compounds. Said compound was selected from the following groups of compounds: Nordihydroguaiaretic acid, Trans-Cinnamaldehyde, Daidzein, Isovitexin, Kaempferol, disulfuram, β-Myrcene, Quercetin, (−)-Epigallocatechin-3-gallate, (+)-Limonene, Myricetin, Quercitrin, Luteolin-7-Glucoside, Morin, Neohesperidin, Hesperidin, Capillarisin, (−)-Epigallocatechin, Luteolin, Hyperoside, Ethyl Myristate, Tamarixetin, Phloretin, Baicalein, Rutin, Baicalin, Apigenin, Naringenin, Hesperetin, (+)-Epicatechin, (−)-Epicatechin-3-gallat, Isoliquritigenin, Silybin, Vitexin, Genistein, Isorhamnetin, gallic acid, Diosmin, 6-Gingerol, (+)-Taxifolin, Wongonin, Protocatechuic acid, (+)-Catechin, β-naphthoflavone, Embelin, Trans-Cinnamic acid, (−)-Epicatechin, Phloridzin, Puerarin, Umbelliferone, Brij 58, Brij 76, Brij 35, Tween 20, Tween 80, Tween 40, PEG 2000, PEG 400, Pluornic F68, and PEG 4000. The novel, low side-effect compound complex which contains pharmaceutically effective doses of isoniazid (INH), disulfuram (DSF) and/or a third compound, bis-nitrophenyl phosphate (BNPP) can reduce isoniazid (INH)-induced side effects, e.g. hepatotoxicity, etc.
    • 本发明的特征在于一种新颖的低副作用药物复合物,其包含药学有效剂量的异烟肼(INH)和药学有效剂量的以下化合物之一。 所述化合物选自以下的化合物组:去甲二氢愈创木酸,反式肉桂醛,大豆黄素,异维生素,山奈酚,二苯甲酰甲基丙三醇,槲皮素,( - ) - 表没食子儿茶素-3-没食子酸酯,(+) - 柠檬烯, ,槲皮素,木犀草素,葡萄糖苷,槲皮素,橙皮苷,橙皮苷,毛林素,( - ) - 表没食子儿茶素,木犀草素,枸橼酸,肉豆蔻酸乙酯, 表儿茶素,( - ) - 表儿茶素-3-加仑,异亮氨酸,水飞蓟宾,维生素,染料木黄酮,异鼠李素,没食子酸,Diosmin,6-姜醇,(+) - 紫杉醇,黄芩素,原儿茶酸,(+) - 儿茶素, ( - ) - 表儿茶素,Phloridzin,葛根素,Umbelliferone,Brij 58,Brij 76,Brij 35,Tween 20,Tween 80,Tween 40,PEG 2000,PEG 400,Pornornic F68和 PEG 4000.含有药学有效剂量异烟肼(INH)的新型低副作用复合物, (DSF)和/或第三化合物,磷酸双硝基苯酯(BNPP)可以减少异烟肼(INH)诱导的副作用,例如, 肝毒性等
    • 2. 发明授权
    • Low side effect pharmaceutical composition containing isoniazid
    • 含有异烟肼的低副作用药物组合物
    • US08304394B2
    • 2012-11-06
    • US13059929
    • 2008-07-23
    • Yoapu Oliver HuTon ho Young
    • Yoapu Oliver HuTon ho Young
    • A61K31/7048A61K31/4409A61K31/661A61K31/06
    • A61K45/06A61K31/4409A61K31/6615A61K31/7048A61K2300/00
    • The present invention features a novel, low side-effect pharmaceutical compound complex, comprising the pharmaceutically effective dose of isoniazid (INH) and pharmaceutically effective dose of one of the following compounds. Said compound was selected from the following groups of compounds: Nordihydroguaiaretic acid, Trans-Cinnamaldehyde, Daidzein, Isovitexin, Kaempferol, disulfuram, β-Myrcene, Quercetin, (−)-Epigallocatechin-3-gallate, (+)-Limonene, Myricetin, Quercitrin, Luteolin-7-Glucoside, Morin, Neohesperidin, Hesperidin, Capillarisin, (−)-Epigallocatechin, Luteolin, Hyperoside, Ethyl Myristate, Tamarixetin, Phloretin, Baicalein, Rutin, Baicalin, Apigenin, Naringenin, Hesperetin, (+)-Epicatechin, (−)-Epicatechin-3-gallat, Isoliquritigenin, Silybin, Vitexin, Genistein, Isorhamnetin, gallic acid, Diosmin, 6-Gingerol, (+)-Taxifolin, Wongonin, Protocatechuic acid, (+)-Catechin, β-naphthoflavone, Embelin, Trans-Cinnamic acid, (−)-Epicatechin, Phloridzin, Puerarin, Umbelliferone, Brij 58, Brij 76, Brij 35, Tween 20, Tween 80, Tween 40, PEG 2000, PEG 400, Pluornic F68, and PEG 4000. The novel, low side-effect compound complex which contains pharmaceutically effective doses of isoniazid (INH), disulfuram (DSF) and/or a third compound, bis-nitrophenyl phosphate (BNPP) can reduce isoniazid (INH)-induced side effects, e.g. hepatotoxicity, etc.
    • 本发明的特征在于一种新颖的低副作用药物复合物,其包含药学有效剂量的异烟肼(INH)和药学有效剂量的以下化合物之一。 所述化合物选自以下的化合物组:去甲二氢愈创木酸,反式肉桂醛,大豆黄素,异维生素,山奈酚,二苯甲酰甲基丙三醇,槲皮素,( - ) - 表没食子儿茶素-3-没食子酸酯,(+) - 柠檬烯, ,槲皮素,木犀草素,葡萄糖苷,槲皮素,橙皮苷,橙皮苷,毛林素,( - ) - 表没食子儿茶素,木犀草素,枸橼酸,肉豆蔻酸乙酯, 表儿茶素,( - ) - 表儿茶素-3-加仑,异亮氨酸,水飞蓟宾,维生素,染料木黄酮,异鼠李素,没食子酸,Diosmin,6-姜醇,(+) - 紫杉醇,黄芩素,原儿茶酸,(+) - 儿茶素, ( - ) - 表儿茶素,Phloridzin,葛根素,Umbelliferone,Brij 58,Brij 76,Brij 35,Tween 20,Tween 80,Tween 40,PEG 2000,PEG 400,Pornornic F68和 PEG 4000.含有药学有效剂量异烟肼(INH)的新型低副作用复合物, (DSF)和/或第三化合物,磷酸双硝基苯酯(BNPP)可以减少异烟肼(INH)诱导的副作用,例如, 肝毒性等